Active

Completed

Historical

Future

Projects: Reducing symptoms of multiple sclerosis using non-invasive neuromodulation

Project summary

A variety of chronic nervous system diseases such as multiple sclerosis (MS) result in reduced ability to control movement, i.e. balance, posture, gait, and hand control. Increased tremor and stiffness are also common symptoms in these diseases. Current treatment methods (typically drugs and physical therapy) aim to slow the progress of the disease and help the patient to compensate for loss of function. In some cases symptoms may be temporarily reduced by drugs or implantable brain “pacemakers”, which require expensive surgery. A new technology called cranial-nerve non-invasive neuromodulation (CN-NINM) has been developed to improve the brain’s ability to reorganize and “normalize” its activity during special physical and occupational therapy exercises.

The goals of this research are to (1) investigate how well CN-NINM improves general movement control in ten patients with MS when combined with specially-designed exercises, and (2) develop optimized training protocols, tailored to the unique rehabilitation requirement of MS by developing an estimate of the best combination of device settings and both the duration and progression of exercises to result in greatest reduction of symptoms.

Anticipated outcome: If successful, this work will demonstrate effectiveness of a new non-invasive neuromodulation treatment for movement disorders associated with multiple sclerosis.

Key Personnel: Kurt Kaczmarek (PI), Yuri Danilov, Mitchell Tyler

Clinical collaborator: Chris Luzzio, UW Dept. Neurology

Opportunities for participation

This phase of the project is complete. We regret that we cannot accept inquiries prior to having a call for subjects.

This was a small-scale pilot study that recruited nine subjects with mild to moderate MS symptoms. Individuals interested in participating in this research may watch our patients and volunteer subjects page.

CN-NINM is experimental and not available for sale or general use.

Funding information

Progress reports